top headlines
Biopharma executives expect partnering and mergers and acquisitions to increase [...]
A peer-reviewed study has found a significant correlation between Olink [...]
Movers & Shakers
sponsored content
AI and Robust Scientific Foundations to Optimize Clinical Trial Operations [...]
Saama’s Chief Customer Success and Growth Officer Ari Srinivasan speaks [...]
In this exclusive interview with Liza Laws for Discover Pharma, [...]
With 89% of AI pilots failing to scale, biopharmas can [...]
Other news
Aravax will present topline Phase 2 clinical trial results for [...]
CPHI Milan will bring pharmaceutical manufacturers, suppliers and sustainability leaders [...]
Laverock Therapeutics is expanding its therapeutic pipeline into in vivo [...]
Merck has highlighted the growing role of open-source chemistry software [...]
Novadip Biosciences has secured €10.4 million in convertible financing to [...]
Andelyn Biosciences is manufacturing Ultragenyx’s newly FDA-approved Fayuvi gene therapy [...]
